| [1] |
Bozic KJ, Ward DT, Lau EC, et al. Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study[J]. J Arthroplasty, 2014, 29(1): 154-156.
|
| [2] |
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785.
|
| [3] |
Havelin LI, Fenstad AM, Salomonsson RA, et al. The Nordic arthroplasty register association a unique collaboration between 3 national hip arthroplasty registries with 280 201 THRs[J]. Acta Orthop, 2009, 80(4): 393-401.
|
| [4] |
B A. D H, A H. Antibiotic prophylaxis for wound infections in total joint arthroplasty：a systematic review[J]. J Bone Joint Surg, 2008, 90(7): 915-919.
|
| [5] |
陈志，周宗科．髋膝关节置换术后假体周围感染的诊治进展[J]．实用骨科杂志，2017，23(3):247-251.
|
| [6] |
Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee[J]. Ann Transl Med, 2015, 3(16): 233-234.
|
| [7] |
Aggarwal VK, Bakhshi H, Ecker NU, et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States[J]. J Knee Surg, 2014, 27(5): 399-405.
|
| [8] |
Jaberi FM, Parvizi J, Haytmanek C, et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty[J]. Clin Orthop Relat Res, 2008, 466(6): 1368-1371.
|
| [9] |
Cross MB, Yi PH, Thomas CF, et al. Evaluation of malnutrition in orthopaedic surgery[J]. J Am Acad Orthop Surg, 2014, 22(3): 193-199.
|
| [10] |
Guo JJ, Yang H, Qian H, et al. The effects of different nutritional measurements on delayed wound healing after hip fracture in the elderly[J]．J Surg Res, 2010, 159(1): 503-508.
|
| [11] |
Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2015, 3(2): 72-81.
|
| [12] |
Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients：Relationship to postoperative wound complications[J]. J Arthroplasty, 1991, 6(4): 321-325.
|
| [13] |
Pitto RP. CORR insights (R): is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty？[J]. Clin Orthop Relat Res, 2015, 473(1): 183-184.
|
| [14] |
Zmistowski B, Tetreault MW, Alijanipour P, et al. Recurrent periprosthetic joint infection：persistent or new infection？[J]. J Arthroplasty, 2013, 28(9): 1486-1489.
|
| [15] |
Nawabi DH, Chin KF, Keen RW, et al. Vitamin D deficiency in patients with osteoarthritis undergoing total hip replacement: a cause for concern？[J]. J Bone Joint Surg Br, 2010, 92B(4): 496-499.
|
| [16] |
Maier GS, Horas K, Seeger JB, et al. Is there an association between periprosthetic joint infection and low vitamin D levels？[J]. Int Orthop, 2014, 38(7): 1499-1504.
|
| [17] |
Stryker LS, Abdel MP, Morrey ME, et al. Elevated postoperative blood glucose and preoperative hemoglobin a1C are associated with increased wound complications following total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95A(9): 808-814.
|
| [18] |
Capozzi JD, Lepkowsky ER, Callari MM, et al. The prevalence of diabetes mellitus and routine hemoglobin a1c screening in elective total joint arthroplasty patients[J]. J Arthroplasty, 2017, 32(1): 304-308.
|
| [19] |
Marchant J, Viens NA, Cook CA, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty[J]. J Bone Joint Surg Am, 2009, 91A(7): 1621-1629.
|
| [20] |
Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications[J]. Arch Surg, 2006, 141(4): 375-380.
|
| [21] |
Chrastil J, Anderson MB, Stevens V, et al. Is hemoglobin a1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty？[J]. J Arthroplasty, 2015, 30(7): 1197-1202.
|
| [22] |
Wang Y, Simpson JA, Wluka AE, et al. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis：a prospective cohort study[J]. Arthritis Res Ther, 2009, 11(2): 1-10.
|
| [23] |
Triantafyllopoulos GK, Soranoglou VG, Sculco TP, et al. Rate and risk factors for periprosthetic joint infection among 36, 494 primary total hip arthroplasties[J]. J Arthroplasty, 2018, 33(4): 1166-1170.
|
| [24] |
Tayton ER, Frampton C, Hooper GJ, et al. The impact of patient and surgical factors on the rate of infection after primary total knee arthroplasty: an analysis of 64 566 joints from the New Zealand Joint Registry[J]. Bone Joint J, 2016, 98B(3): 334-340.
|
| [25] |
Chirca I, Marculescu C. Prevention of infection in orthopedic prosthetic surgery[J]. Infect Dis Clin North Am, 2017, 31(2): 253-263.
|
| [26] |
Schnaser EA, Browne JA, Padgett DE, et al. Perioperative complications in patients with inflammatory arthropathy undergoing total knee arthroplasty[J]. J Arthroplasty, 2015, 30(10): 76-80.
|
| [27] |
Ravi B, Croxford R, Hollands S, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis[J]. Analyst, 2014, 66(2): 254-263.
|
| [28] |
Tada M, Inui K, Sugioka Y, et al. Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs[J]. Clin Rheumatol, 2016, 35(6): 1475-1481.
|
| [29] |
Ding T, Ledingham J, Luqmani R, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies[J]. Rheumatology, 2010, 49(11): 2217-2219.
|
| [30] |
Marculescu CE, Mabry T, Berbari EF. Prevention of surgical site infections in joint replacement surgery[J]. Surg Infect (Larchmt), 2016, 17(2): 152-157.
|
| [31] |
Kunutsor SK, Whitehouse MR, Blom AW, et al. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J/OL]. PLoS One, 2016, 11(3): e0150866. doi： 10.1371/journal.pone.0150866. |
| [32] |
Bozic KJ, Lau E, Kurtz S, et al. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA[J]. Clin Orthop Relat Res, 2012, 470(1): 130-137.
|
| [33] |
Leonard BE. The immune system, depression and the action of antidepressants[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2001, 25(4): 767-780.
|
| [34] |
Babayan RK. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy：a systematic review[J]. J Urol, 2012, 188(6): 2243-2244.
|
| [35] |
Teng SS, Yi CQ, Krettek C, et al. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies[J/OL]. PLoS One, 2015, 10(4): e0125294. doi: 10.1371/journal.pone.0125294. |
| [36] |
Ban KA, Minei JP, Laronga CA, et al. Executive summary of the American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update[J]. Surg Infect (Larchmt), 2017, 18(4, SI): 379-382.
|
| [37] |
Bradley KA, Rubinsky AD, Sun HL, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery[J]. J Gen Intern Med, 2011, 26(2): 162-169.
|
| [38] |
Tϕnnesen H, Nielsen PR, Lauritzen JB, et al. Smoking and alcohol intervention before surgery: evidence for best practice[J]. Br J Anaesth, 2009, 102(3): 297-306.
|
| [39] |
Rezapoor M, Parvizi J. Prevention of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(6): 902-907.
|
| [40] |
George J, Klika AK, Higuera CA. Use of chlorhexidine preparations in total joint arthroplasty[J]. J Bone Jt Infect, 2017, 2(1): 15-22.
|
| [41] |
Colling K, Statz C, Glover J, et al. Pre-operative antiseptic shower and bath policy decreases the rate of S．aureus and methicillin-resistant S．aureus surgical site infections in patients undergoing joint arthroplasty[J]. Surg Infect (Larchmt), 2015, 16(2): 124-132.
|
| [42] |
Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial[J]. Crit Care Med, 2009, 37(6): 1858-1865.
|
| [43] |
Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2017, 99-B(4 Supple B): 3-10.
|
| [44] |
Morrison TN, Chen AF, Taneja MA, et al. Single vs repeat surgical skin preparations for reducing surgical site infection after total joint arthroplasty: a prospective, randomized, double-blinded study[J]. J Arthroplasty, 2016, 31(6): 1289-1294.
|
| [45] |
Shahi A, Eajazi A. Prevention of periprosthetic joint infection: pre-and intraoperative considerations[J]. J Bone Joint Surg Br, 2015, 38(4): 219-221.
|
| [46] |
Broekman ML, Van Beijnum J, Peul WC. Neurosurgery and shaving: what’s the evidence? A review[J]. J Neurosurg, 2011, 115(4): 670-678.
|
| [47] |
Price CS, Williams A, Philips G, et al. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients[J]. Clin Orthop Relat Res, 2008, 466(11): 2842-2847.
|
| [48] |
Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of staphylococcus aureus[J]. N Engl J Med, 2010, 362(1): 9-17.
|
| [49] |
Grothe C, Taminato M, Belasco A, et al. Screening and treatment for staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis[J]. BMC Nephrol, 2014, 15(1): 202-205.
|
| [50] |
Botelho-Nevers E, Gagnaire J, Verhoeven PO, et al. Decolonization of staphylococcus aureus carriage[J]. Med Mal Infect, 2017, 47(5): 305-310.
|
| [51] |
Torres EG, Lindmair-Snell JM, Langan JW, et al. Is preoperative nasal povidone-iodine as efficient and cost-effective as standard methicillin-resistant staphylococcus aureus screening protocol in total joint arthroplasty？[J]. J Arthroplasty, 2016, 31(1): 215-218.
|
| [52] |
Parvizi J, Alijanipour P, Barberi EF, et al. Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections[J]. J Am Acad Orthop Surg, 2015, 23(Suppl): S32-S43.
|
| [53] |
Yang L, Zhou H, Cheng P, et al.A novel bivalent fusion vaccine induces broad immunoprotection against staphylococcus aureus infection in different murine models[J]. Clin Immunol, 2018, 188: 85-93.
|
| [54] |
Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification[J]. Infect Cotrol Hosp Epidemiol, 2012, 33(8): 774-781.
|
| [55] |
J M, K WS, N MR, et al. Current evidence for the use of laminar flow in reducing infection rates in total joint arthroplasty[J]. Open Orthop J, 2015, 9(1): 495-498.
|
| [56] |
G P. AC B, C B. Influence of laminar airflow on prosthetic joint infections：a systematic review[J]. J Hosp Infect, 2012, 81(2): 73-78.
|
| [57] |
Panaahi P, Casper DS, Parvizi J, et al. Operating room traffic is a major concern during total joint arthroplasty[J]. Clin Orthop Relat Res, 2013, 471(1): 343-344.
|
| [58] |
Bedard M, Pelletier-Roy R, Angers-Goulet MA, et al. Traffic in the operating room during joint replacement is a multidisciplinary problem[J]. Can J Surg, 2015, 58(4): 232-236.
|
| [59] |
Guo YP, Wong PM, Li Y, et al. Is double-gloving really protective? A comparison between the glove perforation rate among perioperative nurses with single and double gloves during surgery[J]. Am J Surg, 2012, 204(2): 210-215.
|
| [60] |
Makama JG, Okeme IM, Makamae J, et al. Glove perforation rate in surgery: a randomized, controlled study to evaluate the efficacy of double dloving[J]. Surgl Infect, 2016, 17(4):420-436.
|
| [61] |
Heller S, Rezapoor M, Parvizi J. Minimising. the risk of infection: a peri-operative checklist[J]. Bone Joint J, 2016, 98B(1, A): 18-22.
|
| [62] |
Shohat N, Parvizi J. Prevention of periprosthetic joint infection: examining the recent guidelines[J]. J Arthroplasty, 2017, 32(7): 2040-2046.
|
| [63] |
Albuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty – a systematic review[J]. J Bone Joint Surg Br, 2008, 90B(7): 915-919.
|
| [64] |
Soriano A. CORR insights (R): vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin[J]. Clin Orthop Relat Res, 2017, 475(7): 1775-1778.
|
| [65] |
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery[J]. Surg Infect (Larchmt), 2013, 14(1): 73-156.
|
| [66] |
Havelin LI, Engesaeter LB, Espehaug B, et al. The Norwegian Arthroplasty Register: 11 years and 73, 000 arthroplasties[J]. Acta Orthop Scand, 2000, 71(4): 337-353.
|
| [67] |
Wang J, Zhu C, Cheng T, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty[J/OL]. PLoS One, 2013, 8(12): e82745. doi： 10.1371/journal.pone.0082745. |
| [68] |
Wang H, Qiu GX, Lin J, et al. Antibiotic bone cement cannot reduce deep infection after primary total knee arthroplasty[J]. Orthopedics, 2015, 38(6): e462-e466.
|
| [69] |
Miola M, Bistolfi A, Valsania MC, et al. Antibiotic-loaded acrylic bone cements：an in vitro study on the release mechanism and its efficacy[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(5): 302-305.
|
| [70] |
Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement[J]. J Bone Joint Surg Am, 2006, 88(11): 2487-2500.
|
| [71] |
Van DH, Neut D, Schenk W, et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation[J]. Acta Orthop Scand, 2000, 71(6): 625-629.
|
| [72] |
Kendall RW, Duncan CP, Smith JA, et al. Persistence of bacteria on antibiotic loaded acrylic depots.A reason for caution[J]．Clin Orthop Relat Res, 1996, 329(329): 273-280.
|
| [73] |
Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection[J]. Bone Joint J, 2013, 95-b(11): 1450-1452.
|
| [74] |
Catelas I, Wimmer MA, Utzschneider S. Polyethylene and metal wear particles: characteristics and biological effects[J]. Semin Immunopathol, 2011, 33(3): 257-271.
|
| [75] |
王寿宇，阴宝盛，张卫国．关节置换术后深部感染的预防[J/CD]．中华临床医师杂志(电子版)，2012，17)(17):5013-5015.
|
| [76] |
Cloutier M, Mantovani D, Rosei F. Antibacterial coatings: challenges, perspectives, and opportunities[J]. Trends Biotechnol, 2015, 33(11): 637-652.
|
| [77] |
Wang J, Li J, Guo G, et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver[J]. Scientific reports, 2016, 6: 326-399.
|
| [78] |
Guo G, Zhou H, Wang Q, et al. Nano-layered magnesium fluoride reservoirs on biomaterial surfaces strengthen polymorphonuclear leukocyte resistance to bacterial pathogens[J]. Nanoscale, 2017, 9(2): 875-892.
|
| [79] |
Zhu Y, Zhang F, Chen W, et al. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J]. J Hosp Infect, 2015, 89(2): 82-89.
|
| [80] |
Kapadia BH, Pivec R, Johnson AJ, et al. Infection prevention methodologies for lower extremity total joint arthroplasty[J]. Expert Rev Med Devices, 2013, 10(2): 215-224.
|
| [81] |
Hopper GP, Deakin AH, Crane EO, et al. Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit[J]. J Wound Care, 2012, 21(4): 200-203.
|
| [82] |
Grosso MJ, Berg A, Larussa S, et al. Silver-impregnated occlusive dressing reduces rates of acute periprosthetic joint infection after total joint arthroplasty[J]. J Arthroplasty, 2017, 32(3): 929-932.
|
| [83] |
Gillespie BM, Rickard CM, Thalib L, et al. Use of negative-pressure wound dressings to prevent surgical site complications after primary hip arthroplasty: a pilot RCT[J]. Surg Innov, 2015, 22(5): 488-495.
|
| [84] |
Mortazavi S, Hansen P, Zmistowski BA, et al. Hematoma following primary total hip arthroplasty: a grave complication[J]. J Arthroplasty, 2013, 28(3): 498-503.
|
| [85] |
de Dios-Pérez MS, Cordero-Ampuero J. Reply to: risk factors for infection in total knee arthroplasty, including previously unreported intraoperative fracture and deep venous thrombosis[J]. Rev Esp Cir Ortop Traumatol, 2016, 60(4):268-269.
|
| [86] |
Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95(14): 1256-1264.
|
| [87] |
Huang R, Buckley PS, Scott B, et al. Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(9, S): 39-41.
|
| [88] |
Jenny JY. Infections associated with dental procedures in total hip arthroplasty[J]. J Bone Joint Surg Br, 2000, 82(2):56-59.
|